晚期乳癌電子報分類文章　顯示方式：簡文 | 列表

2009年07月27日

晚期乳癌電子報 第 189 期

分多次使用紫杉醇類藥物併用健澤治療轉移乳癌病人：第二期隨機臨床試驗
Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: A randomised phase II study
European Journal of Cancer, Volume 42, Issue 12, Pages 1797-1806 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:25 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 188 期

在可手術的晚期乳癌病人以及罹患不可手術的乳癌病人，以doxorubicin 與 docetaxel 治療（但縮短療程間隔）的第二期試驗

Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer
Breast Cancer Research and Treatment Volume 97, Number 3 ,Pages: 311 - 318
...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:24 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 187 期

於局部晚期乳癌病人針對 farnesyltransferase 的抑制：併用 tipifarnib 與高劑量 doxorubicin 與 cyclophosphamide 的第一與第二期試驗
Targeted Inhibition of Farnesyltransferase in Locally Advanced Breast Cancer: A Phase I and II Trial of Tipifarnib Plus Dose-Dense Doxorubicin and Cyclophosphamide
Journal of Clinical Oncology, Vol 24, No 19 (July 1), 2006: pp. 3013-3018 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:23 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 186 期

每週使用doxetaxel與截瘤達治療轉移乳癌病人的第二期試驗
Phase II Study of Weekly Docetaxel and Capecitabine in Patients with Metastatic Breast Cancer
Clinical Breast Cancer June 2006 (Vol. 7, No. 02)
...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:22 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 184 期

在局部晚期乳癌或發炎性乳癌病人，在手術前後施以固定療程數的化學治療（併用 5-FU、epirubicin、vinorelbine）以及放射治療的結果
Multidisciplinary Therapy of Locally Far-Advanced or Inflammatory Breast Cancer with Fixed Perioperative Sequence of Epirubicin, Vinorelbine, and Fluorouracil Chemotherapy, Surgery, and Radiotherapy: Long-Term Results
The Oncologist, Vol. 11, No. 6, 563-573, June 2006; doi:10.1634/theoncologist.11-6-563
...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:19 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 185 期

在罹患 HER-2陽性的轉移乳癌病人，使用Herceptin 與docetaxel ，併用或不用carboplatin 治療的效果
BCIRG 007: randomized phase III trial of trastuzumab plus docetaxel with or without carboplatin first line in HER2 positive metastatic breast cancer (MBC).
Citation: Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Par
t I. Vol 24, No. 18S (June 20 Supplement), 2006: LBA516
...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:19 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 183 期

聚乙烯二醇化微脂體 doxorubicin 用於曾接受過傳統anthracycline類藥物治療的轉移乳癌病人之效果：第二期試驗
The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial
British Journal of Cancer (2006) 94, 1615-1620.
doi:10.1038/sj.bjc.6603158 Published online 9 May 2006 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:18 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 182 期

1.
健澤（gemcitabine）併用cisplatin治療轉移乳癌病人的第二期試驗
Phase II study of gemcitabine plus cisplatin in metastatic breast cancer.
Anti-Cancer Drugs. 17(5):565-570, June 2006.

2.
非聚乙烯二醇化的微脂體 doxorubicin 與傳統劑型之 doxorubicin 相比，用在接受過 anthracycline 類藥物之輔助性化學治療的轉移乳癌病人，抗癌效果更好，心臟毒性更低
Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis.
Anti-Cancer Drugs. 17(5):587-595, June 2006. ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:16 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 181 期

1.
併用 oxaliplatin 與 vinorelbine 的治療接受過 anthracycline 類藥物以及紫杉醇類藥物治療的轉移乳癌病人：第二期試驗
Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer.
Anti-Cancer Drugs. 17(3):337-343, March 2006.


2.
每週以紫杉醇（paclitaxel）、5-FU、folinic acid，輔以顆粒球生成素，治療轉移乳癌病人：第二期試驗
Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimu
lating factor support in metastatic breast cancer patients: a phase II study.
Anti-Cancer Drugs. 17(3):345-351, March 2006. ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:14 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 180 期

1.
在接受術前輔助性化學治療的乳癌病人，於手術前或手術後加上 docetaxel的影響
Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
Journal of Clinical Oncology, Vol 24, No 13 (May 1), 2006: pp. 2019-2027

2.
於診斷時即已發現有轉移之乳癌病人，切除主要腫瘤可以改善存活
Complete Excision of Primary Breast Tumor Improves Survival of Patients With Metastatic Breast Cancer at Diagnosis
JCO Early Release, published online ahead of print May 15 2006
Journal of Clinical Oncology, 10.1200/JCO.2005.04.2226 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:10 │ 回應(0) │ 引用(0)
 [第一頁]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  [11]  [下10頁]  [最終頁] 
回頁首▲